Gosebruch Henry is a director or executive at Lakefront Biotherapeutics and is subject to EU Market Abuse Regulation disclosure requirements due to their senior position. Their role provides privileged access to material non-public information, requiring mandatory disclosure of securities transactions in company shares.
1Y Return
+0.1%
Trade history
2
Trade history
2 signal trades· 3 raw disclosed1 transaction excluded from signal rankings. One or more filings for this person appear to relate to account consolidation, account transfers, or portfolio restructuring. Shown below for transparency but excluded from performance calculations and signal feeds.
Side
🇧🇪
Reported purchaseGosebruch HenryEU MAR
LKFTOther
LAKEFRONT BIOTHERAPEUTICS
BE0003818359
~€159K
@ €23.45
🇧🇪
Neutral — compensation/vestingGosebruch HenryEU MAR
LKFTOther
LAKEFRONT BIOTHERAPEUTICS
BE0003818359
Undisclosed
Not an insider buy/sell signal. This transaction is part of a compensation or vesting arrangement. Shares received through remuneration and subsequently sold for tax or liquidity purposes are classified as neutral and excluded from signal analysis.